Patent · US Active

Methods and systems for treating cell proliferation disorders with psoralen derivatives

US8791275B2 · kind B2 · utility

3Cited by
1References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 11, 2013
Grant dateJul 29, 2014
Priority date—
Expiry dateJan 11, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Psoralen compounds of Formula (I):

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.